R. Bell

The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice.

D. Yellon, R. Bell, R. Bell, 2001, Cardiovascular research.

SGLT2 inhibitor, Canagliflozin, attenuates myocardial infarction in the diabetic and non-diabetic heart Short title: SGL2 inhibition attenuates myocardial infarction

D. Yellon, D. Long, M. Kolatsi-Joannou, 2018 .

Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop

B. Ibáñez, G. Vilahur, G. Heusch, 2022, Basic Research in Cardiology.

Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across sixteen countries

J. De Sutter, P. Woudstra, P. van der Harst, 2021, medRxiv.

Hyperglycemic exacerbation of myocardial infarction through SGLT1 - a glucose paradox.

D. Yellon, D. Jafree, M. Kolatsi-Joannou, 2023, medRxiv.

The protection observed during delayed preconditioning of the heart appears independently of iNOS: A study in iNOS knockout mice

D. Yellon, R. Bell, D. Rees, 1999 .